论文部分内容阅读
米力浓属一种新型正性肌力药物，具有选择性地抑制心肌细胞内磷酸二酯酶Ⅲ，增加心肌收缩力的作用。本文于１９９６年１１月～１９９８年３月应用米力浓治疗２０例难治性慢性肺原性心脏病心力衰竭（慢性肺心病心衰），疗效较满意，现将观察结果报告如下：１临床资料１．１...
Milrinone is a new type of inotropic agent that selectively inhibits cardiomyocyte phosphodiesterase III and increases myocardial contractility. This article in November 1996 ~ March 1998 application of milrinone treatment of 20 patients with refractory chronic pulmonary heart disease heart failure (chronic pulmonary heart failure), the effect is more satisfactory, the observations are reported as follows: 1 Clinical Information 1.1 ...